A reasonable initial panel of tests in the elderly patient with unintentional weight loss includes the following: a fecal occult blood test to screen for cancer; a complete blood count to look for infection, deficiency anemia or lymphoproliferative disorder; a chemistry profile to look for evidence of diabetes mellitus, renal dysfunction or dehydration; an ultrasensitive thyroid-stimulating hormone test to look for hypothyroidism or hyperthyroidism; and a urinalysis to look for evidence of infection, renal dysfunction or dehydration. Upper gastrointestinal studies (radiography or endoscopy) may be warranted in patients with symptoms referable to the gastrointestinal system or in patients with persistent weight loss.
Thalidomide has been used by Brazilian physicians as the drug of choice for the treatment of severe ENL since 1965, and by 1996, at least 33 cases of thalidomide embryopathy were recorded in people born in Brazil after 1965.  Since 1994, the production, dispensing, and prescription of thalidomide have been strictly controlled, requiring women to use two forms of birth control and submit to regular pregnancy tests. Despite this, cases of thalidomide embryopathy continue,   with at least 100 cases identified in Brazil between 2005 and 2010.  million thalidomide pills were distributed throughout Brazil in this time period, largely to poor Brazilians in areas with poor access to healthcare, and these cases have occurred despite the controls.
A lot of myths surround injectable hGH and its effects on athletes. Here are some risks you should be aware of. If you buy what may be called "growth hormone," "growth stimulator" or "growth factors" online, it's likely they're not really hGH. Many websites claim to be selling growth hormone, but they're really selling amino acids that don't significantly increase growth hormone levels in your body. Also there's a risk of contracting HIV or other diseases (like hepatitis) if people share needles, because human growth hormone can only be injected, like many steroids.